MAXY Share Price

Open 2.55 Change Price %
High 2.57 1 Day -0.01 -0.39
Low 2.53 1 Week 0.00 0.00
Close 2.53 1 Month 0.00 0.00
Volume 1357690 1 Year 0.00 0.00
52 Week High 74.70
52 Week Low 45.93
MAXY Important Levels
Resistance 2 2.57
Resistance 1 2.55
Pivot 2.54
Support 1 2.51
Support 2 2.49
NASDAQ USA Most Active Stocks
SIRI 4.30 -5.49%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
QQQ 115.70 0.20%
WRES 0.09 0.00%
More..
NASDAQ USA Top Gainers Stocks
QKLS 0.21 110.00%
LOCM 0.09 50.00%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
PERF 1.90 22.58%
ASNA 7.01 20.24%
SBSA 4.60 17.95%
CEMP 7.55 15.27%
XXIA 15.55 14.76%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
AMCF 0.03 -50.00%
VALV 0.03 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
RITT 0.06 -45.45%
DVOX 0.05 -44.44%
More..

Maxygen, Inc. (NASDAQ: MAXY)

MAXY Technical Analysis 3
As on 29th Aug 2013 MAXY Share Price closed @ 2.53 and we RECOMMEND Buy for LONG-TERM with Stoploss of 2.48 & Buy for SHORT-TERM with Stoploss of 2.51 we also expect STOCK to react on Following IMPORTANT LEVELS.
MAXY Target for December
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
Maxygen, Inc. ( NASDAQ USA Symbol : MAXY )
Sector : Health Care Biotechnology: Commercial Physical & Biological Resarch And Other Stocks in Same Sector
GNOM
3.14 -0.01 (-0.32 %)
LT : Strong Buy
ST : Buy
MAXY
2.53 -0.01 (-0.39 %)
LT : Buy
ST : Buy
NRCI
60.10 -0.65 (-1.07 %)
LT : Buy
ST : Buy
OXBT
4.04 0.02 (0.50 %)
LT : Sell
ST : Buy
MAXY Other Details
Segment EQ
Market Capital 69479880.00
Sector Health Care Biotechnology: Commercial Physical & Biological Resarch
Industry
Offical website
MAXY Address
MAXY
N/A
MAXY Latest News
Interactive Technical Analysis Chart Maxygen, Inc. ( MAXY NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Maxygen, Inc.
MAXY Business Profile
Maxygen, Inc. (Maxygen) is a biotechnology company focused on the development of its MAXY-G34 product candidate. MAXY-G34 is a pegylated, granulocyte colony stimulating factor (G-CSF), for the treatment of chemotherapy-induced neutropenia and acute radiation syndrome (ARS). On May 16, 2011, Astellas Pharma Inc. (Astellas) acquired the Company�s interests in Perseid Therapeutics LLC, the Company�s former subsidiary, which included all of the Company�s research and development operations. As a result of the transaction, the Company has reclassified the operating results of Perseid, as well as any related business activities, to discontinued operations. The Company�s wholly owned subsidiaries include Maxygen Holdings (U.S.), Inc., Maxygen ApS and Maxygen Holdings, Inc., and its majority owned subsidiary, Maxygen Holdings LLC.